Adverse events1,008

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,008

Type	Event	Organ system	Group	Affected	At risk
other	Lymph node pain	Blood and lymphatic system disorders	AIN457 300 mg Q4W - CLP Cohort	0	25
other	Lymph node pain	Blood and lymphatic system disorders	Placebo - CLP Cohort	1	12
other	Lymph node pain	Blood and lymphatic system disorders	Any AIN457 300 mg - CLP Cohort	0	33
other	Lymph node pain	Blood and lymphatic system disorders	Placebo to AIN457 300 mg Q2W - CLP Cohort	0	8
other	Lymph node pain	Blood and lymphatic system disorders	AIN457 300 mg Q4W - MLP Cohort	0	24
other	Lymph node pain	Blood and lymphatic system disorders	Placebo - MLP Cohort	0	13
other	Lymph node pain	Blood and lymphatic system disorders	Any AIN457 300 mg - MLP Cohort	0	35
other	Lymph node pain	Blood and lymphatic system disorders	Placebo to AIN457 300 mg Q2W - MLP Cohort	0	11
other	Lymph node pain	Blood and lymphatic system disorders	AIN457 300 mg Q4W - LPP Cohort	0	24
other	Lymph node pain	Blood and lymphatic system disorders	Placebo - LPP Cohort	0	13
other	Lymph node pain	Blood and lymphatic system disorders	Any AIN457 300 mg - LPP Cohort	0	36
other	Lymph node pain	Blood and lymphatic system disorders	Placebo to AIN457 300 mg Q2W - LPP Cohort	0	12
other	Arteriosclerosis coronary artery	Cardiac disorders	AIN457 300 mg Q4W - CLP Cohort	0	25
other	Arteriosclerosis coronary artery	Cardiac disorders	Placebo - CLP Cohort	0	12
other	Arteriosclerosis coronary artery	Cardiac disorders	Any AIN457 300 mg - CLP Cohort	0	33
other	Arteriosclerosis coronary artery	Cardiac disorders	Placebo to AIN457 300 mg Q2W - CLP Cohort	0	8
other	Arteriosclerosis coronary artery	Cardiac disorders	AIN457 300 mg Q4W - MLP Cohort	0	24
other	Arteriosclerosis coronary artery	Cardiac disorders	Placebo - MLP Cohort	0	13
other	Arteriosclerosis coronary artery	Cardiac disorders	Any AIN457 300 mg - MLP Cohort	0	35
other	Arteriosclerosis coronary artery	Cardiac disorders	Placebo to AIN457 300 mg Q2W - MLP Cohort	0	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04300296/events

API reference For AI assistants

Adverse events1,008

Sources 3

Read this list from software.